Utah medical products inc (UTMD)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Sales, net

47,074

46,904

44,828

42,724

41,843

41,998

42,367

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of goods sold

17,545

17,438

17,070

16,051

15,686

15,692

15,671

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency translation tax adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized gain (loss) on investments tax adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sales, net

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

40,225

40,157

40,818

41,590

41,684

41,278

41,120

40,435

39,946

40,493

40,240

40,697

40,720

41,552

41,626

41,921

42,273

37,860

34,155

29,647

0

0

0

Cost of goods sold

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

15,929

15,972

16,140

16,795

16,639

16,295

16,530

16,092

15,904

16,220

15,942

15,871

15,871

16,245

16,427

16,681

16,844

15,460

14,331

13,074

0

0

0

Gross profit

29,529

29,466

27,758

26,673

26,157

26,306

26,671

26,873

26,782

26,395

0

0

0

-

-

-

24,296

24,185

24,678

24,795

25,045

24,983

24,590

24,343

24,042

24,273

24,299

24,827

24,850

25,307

25,198

25,239

25,428

22,400

19,824

16,573

0

0

0

Operating expense
Selling, general and administrative

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

0

0

Research & development

503

483

474

452

456

454

445

440

442

447

0

0

0

-

-

-

476

522

513

518

493

460

475

486

491

491

499

513

540

563

-472

-474

-473

-518

488

445

0

0

0

Total operating expenses

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

0

0

Operating income

17,394

17,632

17,221

17,252

17,827

18,697

19,002

19,279

19,257

19,011

0

0

0

-

-

-

16,086

15,651

16,139

16,141

16,236

16,202

15,466

15,129

14,782

14,828

14,838

15,133

14,970

15,196

14,539

14,118

13,799

11,842

11,187

9,843

0

0

0

Other income

81

-8

17

20

436

437

518

456

-21

-32

0

0

0

-

-

-

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

0

0

Income before provision for income taxes

17,735

17,884

17,563

17,597

18,588

19,459

19,623

19,838

19,339

19,082

0

0

0

-

-

-

16,291

15,545

15,923

15,691

15,697

15,812

15,092

14,774

14,471

14,476

14,312

14,584

14,387

14,537

13,928

13,353

12,875

11,080

10,657

9,594

0

0

0

Provision for income taxes

3,007

3,157

3,801

778

986

904

6,984

10,339

10,278

10,577

0

0

0

-

-

-

3,898

3,702

4,291

4,284

4,374

4,434

3,247

3,180

3,078

3,070

4,115

4,237

4,272

4,368

4,158

4,067

4,008

3,666

3,590

3,297

0

0

0

Net income

14,728

14,727

13,762

16,819

17,602

18,555

12,639

9,499

9,061

8,505

0

0

0

-

-

-

12,393

11,843

11,632

11,407

11,323

11,378

11,846

11,595

11,393

11,406

10,196

10,346

10,115

10,169

9,770

9,286

8,867

7,414

7,067

6,297

0

0

0

Earnings per common share (basic)

0.85

1.17

1.00

0.95

0.84

0.91

1.81

1.15

1.10

-0.67

0.97

1.04

0.95

-

-

-

0.86

0.86

0.81

0.78

0.71

0.80

0.75

0.76

0.73

0.92

0.69

0.71

0.74

0.62

0.74

0.65

0.76

0.50

0.62

0.55

0.37

0.42

0.40

Earnings per common share (diluted)

0.84

1.17

0.99

0.94

0.84

0.91

1.80

1.15

1.09

-0.68

0.97

1.04

0.95

-

-

-

0.85

0.85

0.81

0.77

0.71

0.80

0.75

0.75

0.72

0.91

0.68

0.70

0.73

0.60

0.73

0.65

0.76

0.51

0.61

0.54

0.37

0.42

0.40

Shares outstanding (basic)

3,707

-

3,720

3,721

3,722

-

3,733

3,731

3,725

-

3,719

3,716

3,714

-

-

-

3,753

-

3,753

3,755

3,750

-

3,741

3,750

3,750

-

3,735

3,725

3,711

-

3,689

3,678

3,649

-

3,636

3,626

3,620

3,616

3,631

Shares outstanding (diluted)

3,724

-

3,737

3,735

3,738

-

3,753

3,754

3,748

-

3,738

3,732

3,728

-

-

-

3,770

-

3,768

3,773

3,776

-

3,764

3,775

3,787

-

3,781

3,770

3,757

-

3,726

3,711

3,675

-

3,644

3,645

3,632

3,631

3,651

Other comprehensive income (loss):
Foreign currency translation net of taxes of $0 in all periods

-1,890

1,507

-2,228

-930

-3,302

-2,949

-1,585

23

4,539

3,893

0

0

0

-

-

-

-599

-2,724

-3,504

-4,537

-6,038

-3,252

-676

4,466

3,626

859

1,175

-2,347

0

-

0

0

-

-

-

-

-

-

-

Foreign currency translation net of taxes of $0 and $0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

Unrealized gain on investments net of taxes of $0, $0 and $6

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-7

-2

-3

4

2

1

3

0

2

8

188

194

187

193

0

0

0

-

-

-

-

-

-

Total comprehensive income

12,838

16,234

11,534

15,889

14,300

15,606

11,064

9,532

13,610

12,408

0

0

0

-

-

-

11,787

9,117

8,125

6,874

5,287

8,127

11,172

16,060

15,021

12,273

10,981

9,662

8,455

12,224

0

0

0

-

-

-

-

-

-